Partners

PRISM has assembled a strong multidisciplinary team of outstanding researchers from pharmaceutical companies, research institutions and small and medium enterprises to exploit the rich expertise across sectors and enhance knowledge transfer between academia and industry. The expertise of the team in the fields of neuroscience, psychiatry and neurology is essential to deliver a state-of-the-art research program and advance research for patient benefit. The consortium includes 23 partners from 8 European countries: Belgium, France, Germany, Italy, Netherlands, Spain, Switzerland and the United Kingdom. All PRISM partners are internationally renowned research institutions and world leading preclinical and clinical experts with excellent past performance in large EUprojects. They have distinguished track records in the fields of neuroscience, psychiatry, neurology and (epi-)genetics.

Print this page

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115916. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. This website reflects only the authors' view and the European Commission is not responsible for any use that may be made of the information it contains.

University of Groningen

P1vital® Ltd

Radboud University Medical Centre

Spanish Mental Health Network

University of Bologna

VU University Medical Center

Biotrial

Drug Target ID

University of Exeter

SBGneuro Ltd

concentris research management GmbH

Leiden University Medical Center

Erasmus University Medical Center

European College of Neuropsycho-pharmacology

European Federation of Associations of Families of People with Mental Illness

Boehringer Ingelheim Pharma GmbH & Co. KG

Novartis Pharma AG

Pfizer Inc.

F.Hoffmann-La Roche

Takeda Development Centre Europe Ltd

Eli Lilly and Company Limited

Janssen Research and Development

University Medical Center Utrecht